Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Cervical cancer caused by human papillomavirus (HPV) infections is the fourth most common cancer in women worldwide. Current prophylactic HPV vaccines have achieved promising success in preventing HPV infection. However, still 570,000 new cases were reported in 2018. The current primary treatment fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Huang, Bilian, Zhu, Linjing, Wei, Hongxia, Shi, Haixia, Zhang, Doudou, Yuan, Huanyun, Luan, Linlin, Zheng, Nan, Xu, Shijie, Nawaz, Waqas, Hong, Ying, Wu, Xilin, Wu, Zhiwei
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264373/
https://ncbi.nlm.nih.gov/pubmed/34248960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.678318
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados